Skip to main content

Latest Market News — Page 89

Most recent news items across all covered tickers, sorted chronologically. Wiseek scores each item for market-moving impact; click through for the full AI-ranked analysis.

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

SpaceX IPO: Futures Signal 19% First-Day Pop, High Valuation Poses Long-Term Risk
ProNewsSPCX · Dow Jones Newswires · 2026-06-09
Lisata-Kuva Merger Delayed Again; $1.5M Option for August Extension
ProNewsLSTA · Wiseek News · 2026-06-09
Positive Phase 1 Data for Subcutaneous BRIUMVI in Myasthenia Gravis; TG Therapeutics Initiates Registration-Directed Phase 2 Trial
ProNewsTGTX · GlobeNewswire · 2026-06-09
Sigma Lithium Wins State Court Appeal, Overturning $10M Collateral Decision
ProNewsSGML · TMX Newsfile · 2026-06-09
Comstock, Jericho Energy Ventures Finalize AI Infrastructure JV, Comstock Commits Up To $10M
ProNewsCHCI · ACCESS Newswire · 2026-06-09
APi Group Completes Onyx-Fire Acquisition, Updates Full-Year Guidance
ProNewsAPG · Dow Jones Newswires · 2026-06-09
Corvus Invests $5M in Angel Pharma to Advance Soquelitinib Trials in China
NewsCRVS · GlobeNewswire · 2026-06-09
QTREX Awarded $1M Grant for 'World's First' Quantum Computing Material
NewsQTEX · GlobeNewswire · 2026-06-09
Schmid Group to nearly double China manufacturing capacity with €11M campus investment
ProNewsSHMD · Reuters · 2026-06-09
U.K. Regulator Launches Antitrust Review of Paramount's $81B Warner Takeover
ProNewsPSKY · Dow Jones Newswires · 2026-06-09
J.M. Smucker Q4 Adjusted EPS Jumps 20%, Beats Estimates; Sales Also Top Forecasts
ProNewsSJM · Reuters · 2026-06-09
SailPoint Projects Q2 Revenue Between $308M and $312M
ProNewsSAIL · Dow Jones Newswires · 2026-06-09
FDA Aligns with Alterity on Pivotal Phase 3 Design for ATH434 in MSA, De-risking Development
ProNewsATHE · GlobeNewswire · 2026-06-09
Kraig Biocraft Labs Achieves New Record: Delivers Nearly 2.5 Metric Tons of Recombinant Spider Silk
ProNewsKBLB · GlobeNewswire · 2026-06-09
Workday Boosts Canadian Public Sector Presence, Capitalizing on Government AI Modernization
NewsWDAY · Reuters · 2026-06-09
22nd Century Redeems $2.01M Preferred Stock, Raises $0.46M via Warrant Inducement
NewsXXII · Wiseek News · 2026-06-09
DraftKings May Volume Surges: Predictions Up 24% MoM, Total Up 34%
ProNewsDKNG · Wiseek News · 2026-06-09
Opaganib Receives FDA Rare Pediatric Disease Designation, Opening Path to Valuable Priority Review Voucher
ProNewsRDHL · Reuters · 2026-06-09
Kymera's KT-485 Enters Phase 1 Trial, Triggers $20M Sanofi Milestone with $975M Potential
ProNewsKYMR · Reuters · 2026-06-09
UNFI Narrows Full-Year Sales Outlook to $31.1B-$31.3B
ProNewsUNFI · Dow Jones Newswires · 2026-06-09
Cartesian Therapeutics Licenses In Vivo CAR-T Platform to Westgene, Clinical Trial to Start 2H 2026
ProNewsRNAC · Reuters · 2026-06-09
Invivyd Doses First Patients in LIBERTY Phase 3 Trial for VYD2311 COVID Antibody
ProNewsIVVD · GlobeNewswire · 2026-06-09
CECO Environmental Projects $1.275B-$1.375B Revenue for 2026 Post-Acquisition
ProNewsCECO · Dow Jones Newswires · 2026-06-09
MIND Technology Q1'26 EPS Estimate Drops to $0.00 Amid Continued Weakness
NewsMIND · Wiseek News · 2026-06-09
Stitch Fix Q3'26 EPS Estimate at $(0.06) Ahead of June 10 Earnings
NewsSFIX · Wiseek News · 2026-06-09
FingerMotion Enters Edge AI Compute Market via BlueFlare MOU, Plans First Alberta Site
NewsFNGR · TMX Newsfile · 2026-06-09
JM Smucker Issues FY Adjusted EPS Guidance of $9.75-$10.00
ProNewsSJM · Dow Jones Newswires · 2026-06-09
Aclarion Partners with PRIA Healthcare to Accelerate Nociscan Reimbursement, US Commercial Adoption
ProNewsACON · GlobeNewswire · 2026-06-09
Nathan's Famous FY26 Profit Drops, EPS Down to $4.85; Declares $0.50 Dividend
ProNewsNATH · Wiseek News · 2026-06-09
Titan Machinery Q1 Revenue Beats Estimates by 7.6% at $522.4M
ProNewsTITN · Reuters · 2026-06-09